These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 1260031)

  • 1. Identification of an active site histidine in urokinase.
    Ong EB; Johnson AJ; Schoellmann G
    Biochim Biophys Acta; 1976 Mar; 429(1):252-7. PubMed ID: 1260031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A functionally active heavy chain derived from human high molecular weight urokinase.
    Sumi H; Robbins KC
    J Biol Chem; 1983 Jul; 258(13):8014-9. PubMed ID: 6345538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification and characterization of two forms of urokinase.
    Soberano ME; Ong EB; Johnson AJ; Levy M; Schoellmann G
    Biochim Biophys Acta; 1976 Oct; 445(3):763-73. PubMed ID: 974102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification of urokinase by affinity chromatography.
    Holmberg L; Bladh B; Astedt B
    Biochim Biophys Acta; 1976 Aug; 445(1):215-22. PubMed ID: 953032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A proenzyme form of human urokinase.
    Wun TC; Ossowski L; Reich E
    J Biol Chem; 1982 Jun; 257(12):7262-8. PubMed ID: 6806270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of high molecular weight urokinase and low molecular weight urokinase.
    Nobuhara M; Sakamaki M; Ohnishi H; Suzuki Y
    J Biochem; 1981 Jul; 90(1):225-32. PubMed ID: 7026550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of human high- and low-molecular-weight urokinases. Analysis of their active site.
    Reboud-Ravaux M; Desvages G
    Biochim Biophys Acta; 1984 Dec; 791(3):333-41. PubMed ID: 6518162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transport of urokinase across the intestinal tract of normal human subjects with stimulation of synthesis and/or release of urokinase-type proteins.
    Toki N; Sumi H; Sasaki K; Boreisha I; Robbins KC
    J Clin Invest; 1985 Apr; 75(4):1212-22. PubMed ID: 3921568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the primary structure of bovine high-molecular-weight kininogen. Amino acid sequence of a fragment ("histidine-rich peptide") released by plasma kallikrein.
    Han YN; Komiya M; Iwanaga S; Suzuki T
    J Biochem; 1975 Jan; 77(1?):55-68. PubMed ID: 1169237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of specific sites involved in ligand binding by photoaffinity labeling of the receptor for the urokinase-type plasminogen activator. Residues located at equivalent positions in uPAR domains I and III participate in the assembly of a composite ligand-binding site.
    Ploug M
    Biochemistry; 1998 Nov; 37(47):16494-505. PubMed ID: 9843416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and characterization of urokinase from human plasma.
    Wun TC; Schleuning WD; Reich E
    J Biol Chem; 1982 Mar; 257(6):3276-83. PubMed ID: 7037781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A specific disulfide bond associated with the activity of human urokinase. Its topological identification and reductive cleavage followed by kinetic changes in enzymatic reaction and affinity labeling.
    Miwa N; Sawada T; Suzuki A
    Eur J Biochem; 1984 May; 140(3):539-45. PubMed ID: 6723647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the catalytic histidine residue participating in the charge-relay system of carboxypeptidase Y.
    Jung G; Ueno H; Hayashi R; Liao TH
    Protein Sci; 1995 Nov; 4(11):2433-5. PubMed ID: 8563642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The susceptibility of urokinase to affinity labeling by peptides of arginine chloromethyl ketone.
    Kettner C; Shaw E
    Biochim Biophys Acta; 1979 Jul; 569(1):31-40. PubMed ID: 465506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of the alkaline mesentericopeptidase active site by means of peptide chloromethyl ketones.
    Raykova D; Stambolieva N; Dorovska-Taran V; Blagoev B
    Biochim Biophys Acta; 1978 Nov; 527(1):108-14. PubMed ID: 718953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid isolation of high molecular weight urokinase from native human urine.
    Huber K; Kirchheimer J; Binder BR
    Thromb Haemost; 1982 Jun; 47(3):197-202. PubMed ID: 7051408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physicochemical properties of highly purified kidney cultured plasminogen activator (single chain urokinase).
    Sumi H; Kosugi T; Matsuo O; Mihara H
    Nihon Ketsueki Gakkai Zasshi; 1982 Feb; 45(1):119-28. PubMed ID: 7051725
    [No Abstract]   [Full Text] [Related]  

  • 18. Purification of high molecular weight urokinase from human urine and comparative study of two active forms of urokinase.
    Shibatani T; Kakimoto T; Chibata I
    Thromb Haemost; 1983 Apr; 49(2):91-5. PubMed ID: 6346574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of urokinase by complex formation with human alpha1-antitrypsin.
    Clemmensen I; Christensen F
    Biochim Biophys Acta; 1976 Apr; 429(2):591-9. PubMed ID: 1083251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase.
    Vassalli JD; Baccino D; Belin D
    J Cell Biol; 1985 Jan; 100(1):86-92. PubMed ID: 3880760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.